{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:32Z","timestamp":1792593692144,"version":"4.5.0"},"reference-count":10,"publisher":"MyJove Corporation","issue":"226","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68992","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:45Z","timestamp":1766188845000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Severe Skin Adverse Reactions Caused by Cetuximab"],"prefix":"10.3791","author":[{"given":"Ya-Ting","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"5","key":"ref1","first-page":"519","type":"journal-article","article-title":"Cutaneous adverse reactions to cetuximab: management and impact on quality of life","volume":"20","author":"Wong","year":"2015","unstructured":"Wong, R. et al. Cutaneous adverse reactions to cetuximab: management and impact on quality of life. Oncologist. 20 (5), 519-526 (2015).","journal-title":"Oncologist"},{"issue":"15","key":"ref2","first-page":"1688","type":"journal-article","article-title":"Cetuximab-induced rash and survival in colorectal cancer patients","volume":"34","author":"Van Cutsem","year":"2016","unstructured":"Van Cutsem, E. et al. Cetuximab-induced rash and survival in colorectal cancer patients. J Clin Oncol. 34 (15), 1688-1696 (2016).","journal-title":"J Clin Oncol"},{"issue":"21","key":"ref3","first-page":"2310","type":"journal-article","article-title":"Skin toxicity and clinical outcome with cetuximab plus chemotherapy in head and neck cancer: relation with expression of skin-related biomarkers","volume":"35","author":"Vermorken","year":"2017","unstructured":"Vermorken, J. B. et al. Skin toxicity and clinical outcome with cetuximab plus chemotherapy in head and neck cancer: relation with expression of skin-related biomarkers. J Clin Oncol. 35 (21), 2310-2317 (2017).","journal-title":"J Clin Oncol"},{"issue":"suppl 8","key":"ref4","first-page":"261","type":"journal-article","article-title":"Severe skin reactions with cetuximab: incidence, management and impact on survival","volume":"29","author":"Peeters","year":"2018","unstructured":"Peeters, M. et al. Severe skin reactions with cetuximab: incidence, management and impact on survival. Ann Oncol. 29 (suppl 8), 261-266 (2018).","journal-title":"Ann Oncol"},{"issue":"2","key":"ref5","first-page":"367","type":"journal-article","article-title":"Cutaneous adverse effects with cetuximab therapy","volume":"80","author":"Baselga","year":"2019","unstructured":"Baselga, J. et al. Cutaneous adverse effects with cetuximab therapy. J Am Acad Dermatol. 80 (2), 367-376 (2019).","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"ref6","first-page":"178","type":"journal-article","article-title":"Risk factors for severe cutaneous adverse reactions to cetuximab in colorectal cancer patients","volume":"32","author":"Lee","year":"2020","unstructured":"Lee, S. J. et al. Risk factors for severe cutaneous adverse reactions to cetuximab in colorectal cancer patients. J Chemother. 32 (3), 178-182 (2020).","journal-title":"J Chemother"},{"issue":"7","key":"ref7","first-page":"475","type":"journal-article","article-title":"Management of cetuximab-induced dermatologic toxicities: a systematic review","volume":"17","author":"Martino","year":"2021","unstructured":"Martino, M. et al. Management of cetuximab-induced dermatologic toxicities: a systematic review. J Oncol Pract. 17 (7), 475-481 (2021).","journal-title":"J Oncol Pract"},{"issue":"3","key":"ref8","first-page":"e17592","type":"journal-article","article-title":"Cutaneous adverse effects of cetuximab: a comprehensive review","volume":"36","author":"Garc\u00eda-Romero","year":"2023","unstructured":"Garc\u00eda-Romero, D. et al. Cutaneous adverse effects of cetuximab: a comprehensive review. Dermatol Ther. 36 (3), e17592 (2023).","journal-title":"Dermatol Ther"},{"issue":"24","key":"ref9","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1002\/cam4.3564","type":"journal-article","article-title":"Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial","volume":"9","author":"Ooki","year":"2020","unstructured":"Ooki, A., Morita, S., Tsuji, A. et al. Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial. Cancer Med. 9 (24), 9419-9430 (2020).","journal-title":"Cancer Med"},{"issue":"6","key":"ref10","first-page":"1234","type":"journal-article","article-title":"Clinical features and management of severe cetuximab-induced cutaneous reactions: a single-center experience","volume":"27","author":"Liu","year":"2024","unstructured":"Liu, X. et al. Clinical features and management of severe cetuximab-induced cutaneous reactions: a single-center experience. Oncol Lett. 27 (6), 1234-1240 (2024).","journal-title":"Oncol Lett"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68992\/a-case-of-severe-skin-adverse-reactions-caused-by-cetuximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:01:50Z","timestamp":1792591310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68992\/a-case-of-severe-skin-adverse-reactions-caused-by-cetuximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":10,"journal-issue":{"issue":"226","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68992","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}